| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care.
|
Hum Reprod
|
2007
|
6.08
|
|
2
|
International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009.
|
Fertil Steril
|
2009
|
4.30
|
|
3
|
A systematic review of tests predicting ovarian reserve and IVF outcome.
|
Hum Reprod Update
|
2006
|
4.24
|
|
4
|
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
|
Hum Reprod Update
|
2009
|
3.05
|
|
5
|
National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys.
|
PLoS Med
|
2012
|
2.78
|
|
6
|
Serum anti-Mullerian hormone throughout the human menstrual cycle.
|
Hum Reprod
|
2006
|
2.37
|
|
7
|
Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE†.
|
Hum Reprod
|
2014
|
1.77
|
|
8
|
Ovarian hyperstimulation syndrome.
|
Fertil Steril
|
2008
|
1.46
|
|
9
|
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
|
Hum Reprod Update
|
2014
|
1.35
|
|
10
|
Diagnostic evaluation of the infertile female: a committee opinion.
|
Fertil Steril
|
2012
|
1.32
|
|
11
|
Diagnostic evaluation of the infertile male: a committee opinion.
|
Fertil Steril
|
2015
|
1.30
|
|
12
|
Biomarkers of ovarian response: current and future applications.
|
Fertil Steril
|
2013
|
1.25
|
|
13
|
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.
|
Hum Reprod Update
|
2013
|
1.23
|
|
14
|
Complications of IVF and ovulation induction.
|
Hum Reprod
|
2005
|
1.21
|
|
15
|
The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments.
|
Hum Reprod
|
2012
|
0.94
|
|
16
|
Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
|
Fertil Steril
|
2014
|
0.88
|
|
17
|
First fully automated immunoassay for anti-Müllerian hormone.
|
Clin Chem Lab Med
|
2014
|
0.88
|
|
18
|
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
|
Fertil Steril
|
2016
|
0.83
|